STOCKS TELEGRAPH

Tag: Cigna

  • Cigna Group (CI) Gains Investor Interest In Pre-Hour Trading

    Cigna Group (CI) Gains Investor Interest In Pre-Hour Trading

    Shares of The Cigna Group (NYSE: CI) saw a notable rise this morning, as the company reinforced its financial strategy. As of the latest pre-market trading, CI stock had increased 9.16% to trade at $349.06, following the company’s reaffirmation of its financial priorities. With plans to engage with stakeholders in upcoming weeks, Cigna aims to solidify its position with strong earnings projections, disciplined acquisition criteria, and a focus on capital deployment.

    Strategic Commitment and Forecasts

    To achieve the mile stone of $28.40 per share for annual consolidated adjusted income from operations, Cigna Group executives are getting ready for a series of meetings with analysts and investors. In 2025, Cigna anticipates that adjusted EPS will increase by at least 10%.

    Furthermore, Cigna has stated that it is not looking into a possible merger with Humana Inc. in response to allegations of such a move. CI reaffirmed that it will only take into account acquisitions that have a solid strategic and financial basis and a high chance of success.

    Allocation of Capital Strategically

    A key element of Cigna’s strategy is raising shareholder value through targeted financial measures like dividends and share buybacks. Cigna repurchased $6 billion worth of stock so far this year, including $1 billion in the fourth quarter.

    With the proceeds from the projected sale of its Medicare business in early 2025, CI plans to continue its buyback program in 2025. Its prudent capital allocation approach is demonstrated by the $5.3 billion in buyback authorization that remains.

    Cigna extended the Medicare Advantage Network.

    Cigna Healthcare, a division of the Cigna Group, and Alabama-based Infirmary Health have teamed together to increase access to Medicare Advantage in-network services. Through this agreement, Infirmary Health’s vast network of hospitals and doctors across Alabama, portions of Florida, and southern Mississippi is now accessible to Cigna’s Medicare Advantage consumers.

    With an emphasis on value-based care, this alliance seeks to save costs, improve treatment quality, and improve health outcomes for Medicare Advantage enrollees. Cigna’s regional reach and dedication to offering seniors affordable, high-quality healthcare alternatives are strengthened by this partnership.

  • The Cigna Group (CI): Stock Surged After Analyst Upgrade

    The Cigna Group (CI): Stock Surged After Analyst Upgrade

    The Cigna Group (NYSE: CI) equity experienced notable gains during the most recent trading session, marking an ascent of 16.68% to conclude the session at $301.97. This positive momentum in Cigna Group’s stock can be attributed to an upgraded rating bestowed by the esteemed analyst firm Jefferies. Notably, on Monday, Jefferies reassessed its stance on CI stock, shifting from a “Hold” to a more favorable “Buy” rating, concurrently adjusting the price target from $335 to $341.

    The surge in Cigna Group (CI) stock is further linked to its decision to forego a merger arrangement in favor of implementing a shares buyback strategy. Reports emerged on Sunday confirming Cigna’s discontinuation of negotiations for the acquisition of its rival, Humana.

    The termination of the deal talks was primarily attributed to the parties’ inability to reach a consensus on the pricing aspect. However, Cigna promptly disclosed its intention to initiate share repurchases. The Board of Directors of CI has sanctioned a cumulative increase of $10 billion in incremental share repurchase authorization, augmenting the company’s total share repurchase authority to $11.3 billion.

    The company anticipates allocating a significant portion of its discretionary cash flow towards share repurchases in 2024. Cigna envisions executing share repurchases totaling at least $5 billion of common stock by the conclusion of the first half of 2024. Part of this repurchase is slated to transpire through an accelerated share repurchase program scheduled for the first quarter of 2024.

    Cigna Group justifies its commitment to share repurchases by highlighting the perceived undervaluation of its shares, emphasizing that such buybacks represent a value-enhancing capital deployment. This strategic approach aligns with Cigna’s broader commitment to supporting high-quality care, enhancing affordability, and fostering better health outcomes.

    Emphasizing a comprehensive outlook and strategic opportunities, Cigna is poised to maintain financial discipline while steadfastly executing its strategy. The company remains committed to delivering value for its shareholders and strategically investing in future endeavors.